This week: data breaches hit multiple health systems, a multi-site study questions archived block viability for HER2 re-testing, and we examine whether ‘autonomous’ lab claims hold up.
Also in this issue:
- Why recent hacks should trigger an LIS vulnerability scan
- Archived tissue and the HER2-low re-testing challenge
- Can tissue trimmings save your QNS problem?
- The ‘autonomous lab’ claim: marketing or real?
- Secure your chain of custody with CyteSafe
Top Stories
Multi-State Health Hacks Expose 30,000 Patient Records
Hacking incidents at health facilities in Alabama, New Hampshire, Indiana, and other states have compromised patient data. The breaches targeted interconnected health networks, raising concerns about LIS security and vendor access points.
Why this matters:
- Labs with external-facing vendor connections are high-value targets
- HIPAA-compliant chain of custody now a security imperative, not just regulatory
- Affected systems span multiple states and facility types
Key Takeaway: Interconnected health networks amplify breach exposure, making vendor access controls a frontline defense.
Action Step: Risk and compliance officers: schedule a vulnerability scan on all LIS systems with external vendor access this week.
Archive Age and HER2 Scores: What Labs Need to Know
A multi-institutional study examined HER2-low and HER2-ultralow testing on archived breast cancer tissue. Results show that sample size, antibody clone selection, and block age can all shift diagnostic scores, sometimes significantly.
Why this matters:
- Block age and fixation quality directly affect biomarker accuracy
- Clone choice matters: different antibodies yield different scores on the same sample
- Retrospective molecular testing will only increase as new markers enter practice
Key Takeaway: Long-term archive integrity is now a clinical requirement, not just a storage concern.
Action Step: Histology managers: audit fixation and storage SOPs for blocks from the past five years to confirm viability for molecular re-testing.
Tissue Trimmings May Reduce QNS Results
New commentary explores whether tissue trimmings, often discarded during embedding, can serve as a DNA source. For small biopsies where primary tissue is exhausted, trimmings could prevent ‘quantity not sufficient’ results.
Why this matters:
- Trimmings offer a fallback when primary diagnostic tissue runs out
- Particularly relevant for small biopsies with limited material
- Requires validation before routine clinical use
Key Takeaway: Salvaging trimmings could reduce QNS rates for high-risk small biopsy cases.
Action Step: Lab directors: review specimen processing SOPs to determine if trimmings should be salvaged or archived for high-risk small biopsy cases.
🌶️ Spotlight Opinion: The ‘Autonomous Lab’ Claim Deserves Skepticism
A viral claim that AI systems autonomously designed and ran 36,000+ wet lab experiments has drawn sharp criticism. Many argue these are high-volume micro-assays on standard pipetting robots, not true autonomous science.
- Critics say ‘autonomous’ is marketing language for established robotic automation
- True AI-driven experimental design remains operationally immature
- Over-investing in unproven tech carries real budget risk
Key Takeaway: Before approving capital spend on ‘AI-driven’ lab platforms, demand proof of operational maturity beyond rebranded automation.
GPT5 Autonomously Designed and Executed 36000 Wet Lab Experiments • 224 upvotes, 75 comments
Quick Hits
AI Assists Micrometastasis Detection in Lymph Nodes
AI-augmented review of nodal specimens can flag micrometastases that manual screening might miss, improving diagnostic accuracy for pathologists.
Autopsy Records and Malpractice Liability
Rigorous chain of custody and detailed archival documentation for autopsy specimens remain essential for defending against medical malpractice claims.
NSH Awards Nominations Now Open
Nominating staff for National Society for Histotechnology awards is a low-cost retention strategy during the ongoing labor shortage.
Lock Down Your Specimen Chain of Custody
With breaches hitting health networks and archival quality under the microscope for biomarker re-testing, now is the time to evaluate your traceability and storage practices.
- Strengthen traceability across your specimen workflow
- Get expert guidance on compliant archival and retrieval
- Reduce risk with storage solutions built for labs